Los Angeles, CA - 
(NewMediaWire) - June 29, 2021 - The Schall Law Firm, a
national shareholder rights litigation firm, announces the filing of a class
action lawsuit against Athira Pharma, Inc. (“Athira” or “the Company”) (NASDAQ: ATHA)
for violations of the federal securities laws.
Investors who purchased the
Company's shares pursuant and/or traceable to the Company’s initial public
offering conducted in September 2020 (the “IPO”), or between September 18, 2020
and June 17, 2021, both dates inclusive (the “Class Period”), are encouraged to
contact the firm before August 20, 2021.
If you are a shareholder who
suffered a loss, click here to participate.
We also encourage you to contact
Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los
Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You
can also reach us through the firm's website at www.schallfirm.com,
or by email at brian@schallfirm.com.
The class, in this case, has not
yet been certified, and until certification occurs, you are not represented by
an attorney. If you choose to take no action, you can remain an absent class
member.
According to the Complaint, the
Company made false and misleading statements to the market. Research performed
by Athira CEO and President Leen Kawas was tainted by scientific misconduct.
Kawas allegedly engaged in the manipulation of key data in the research through
the manipulation of Western blot images. The tainted research was of critical
importance to the Company’s efforts to develop treatments for Alzheimer’s. The
Company’s research and development efforts were based on invalid data. Based on
these facts, the Company’s public statements were false and materially
misleading throughout the class period. When the market learned the truth about
Athira, investors suffered damages.
Join the case to recover your losses.
The Schall Law Firm represents
investors around the world and specializes in securities class action lawsuits
and shareholder rights litigation.
This press release may be
considered Attorney Advertising in some jurisdictions under the applicable law
and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
SOURCE:
The Schall Law Firm
